Vetigenics is a clinical-stage animal health biotechnology company focused on developing antibody therapeutics for pets. The company is advancing therapies targeting autoimmune diseases, obesity, and allergies, aiming to improve pet health through innovative biotechnological solutions.
Leadership & Board
Current Number of Employees11
Current LinkedIn Followers892
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$6M
Total Amount Raised$6M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$6M
Latest Funding Amount$6M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Vetigenics had 11 employees as of April 6, 2026. The number of employees increased by 0 (0.00%) week-over-week.
11Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Vetigenics had 892 followers as of April 6, 2026. The number of followers increased by 1 (0.11%) week-over-week.
892Latest Followers Count
1(0.11%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.